Global Expansion Medicomm has a broad international footprint with operations in 50 countries and sales in over 95, supported by 10 fully controlled manufacturing plants across North America, Europe and Asia. This presents cross-border selling opportunities for infection control and single-use products across multiple healthcare and industrial markets.

Strategic Glove Production Significant investment in new nitrile glove production facilities in London, Ontario and associated funding from government programs signals a growing capacity to supply domestically and internationally. Sales targets could focus on nitrile glove demand from hospitals, clinics and industrial sectors amid supply resilience needs.

Broad Market Reach With products spanning medical, dental, industrial, veterinary, laboratory and health and beauty markets, Medicom’s diversified portfolio provides multiple entry points for infection control and single-use disposables, enabling tailored propositions to different buyer personas and procurement cycles.

Public Market Recognition Repeated recognition as a Canada’s Best Managed Company and proven surge during epidemics highlight credibility and resilience. This can be leveraged to pursue partnerships, co-branding, and tenders in public health and large healthcare networks seeking reliable supply partners.

Tech-Driven Selling Adoption of tools like Power BI, SharePoint, Azure AD and Pardot indicates a data-informed, CRM-enabled sales approach. Opportunities exist to optimize account targeting, pipeline forecasting and digital marketing to accelerate conversions in high-potential regions and verticals.